# VN30 Value Investing OS --- Initial Portfolio Review

**Path:** `08_PRODUCTION/INITIAL_PORTFOLIO_REVIEW.md`\
**Milestone:** M8 --- Production Readiness & Live Portfolio Onboarding\
**Version:** 0.1 --- Approval Candidate\
**Status:** READY FOR APPROVAL REVIEW --- LIVE REVIEW NOT EXECUTED\
**Governing baselines:** VVIOS v1.0 M1--M7 and approved M8
production/onboarding contracts

## 1. Purpose

Define the first production portfolio review after the real portfolio,
data, and initial scoring have passed their required gates. This file
freezes the review contract and acceptance logic; it contains no live
recommendations.

The initial review applies M1--M5 without preferential treatment for
legacy holdings and without automatically selling positions merely
because they predate VVIOS.

## 2. Preconditions

Live review requires: reconciled portfolio state; accepted initial
snapshot; valid current VN30 universe; required data gates PASS;
accepted initial scoring run; release/model/data identities; no material
unexplained financial discrepancy; and no Critical/Major blocker that
invalidates decision support.

If required evidence is unavailable, affected decisions remain
blocked/pending under governing rules.

## 3. Mandatory Decision Sequence

**Business Quality → Financial Health → Growth → Industry → Valuation →
Risks → Market / Money Flow → Technical Entry → Existing Portfolio →
Opportunity Cost → Final Decision**

No single metric overrides the sequence unless an approved veto/gate
explicitly permits it.

## 4. Allowed Final States

Exactly one governing state: `STRONG BUY`, `BUY`, `ACCUMULATE`, `HOLD`,
`REDUCE`, `SELL`, or `AVOID`.

Apply approved ownership semantics: BUY vs ACCUMULATE depends on
ownership; AVOID applies to unowned names; PENDING/execution statuses
are not positive capital states.

## 5. Existing Holdings

A pre-VVIOS holding must pass the same logic as any investment. It is
not automatically sold because it was bought before VVIOS, falls outside
Top 10, is below cost, or is above cost. It is not automatically held to
avoid realizing a loss.

Current thesis, valuation, risk and forward opportunity govern the
review.

## 6. Cost Basis and Behavioral Boundary

Cost basis is accounting evidence, not intrinsic value. Explicitly
prevent anchoring, breakeven-only holding, automatic selling at +20%,
and averaging down solely because price fell. A 20% gain remains a
review trigger only.

## 7. Thesis Review

For every holding record current thesis, thesis status, positives,
risks, evidence changes, invalidation conditions and review trigger.

Thesis status: `INTACT`, `WEAKENED`, `BROKEN`, or
`INSUFFICIENT_EVIDENCE`.

Do not infer thesis status from price movement alone and do not
fabricate an original thesis for legacy positions.

## 8. Required Decision Record

Record at minimum: Decision ID, timestamp, Data As-Of,
system/policy/model versions, Data Snapshot ID, Scoring Run ID, ticker,
ownership, score/rank/confidence, thesis, positives, risks, valuation,
market/money-flow, technical entry, portfolio context, opportunity cost,
final state, suggested action, invalidation conditions, review trigger
and execution sub-status where applicable.

## 9. Valuation

Do not equate low P/E with cheap, high P/E with expensive, falling price
with undervaluation, or rising price with overvaluation. Use the
approved forward-looking valuation and required-return rules.
Valuation-only exit must respect approved switching/forward-return
hurdles.

## 10. Risk and Portfolio Context

Review security risk, financial health, industry/regulatory risk,
valuation risk, single-name/sector concentration, liquidity/cash,
drawdown, residual risk and applicable small-NAV exceptions.

A strong company can still be an inappropriate add if concentration/risk
constraints fail.

Drawdown is a review/risk trigger, not a mechanical buy/sell signal.

## 11. Opportunity Cost

New-capital or switching actions must evaluate expected forward return,
thesis/confidence, valuation, risk, fees/taxes where relevant,
concentration and the approved switching hurdle. A holding is not
replaced merely because another ticker ranks slightly higher.

## 12. Market, Money Flow and Technical Entry

Market/money-flow evidence is contextual. Technical analysis is
principally an execution/timing layer. Neither creates a long-term
thesis nor overrides failed investability/valuation/risk gates.

## 13. Portfolio-Level Execution Summary

  Field                       Value
  --------------------------- --------------
  Review ID                   NOT EXECUTED
  Portfolio Snapshot ID       NOT EXECUTED
  Data Snapshot ID            NOT EXECUTED
  Scoring Run ID              NOT EXECUTED
  Review As-Of                NOT EXECUTED
  NAV                         NOT EXECUTED
  Cash / Cash Weight          NOT EXECUTED
  Holdings Count              NOT EXECUTED
  Largest Position / Sector   NOT EXECUTED
  Drawdown State              NOT EXECUTED
  Risk Exceptions             NOT EXECUTED
  Overall Review Status       NOT EXECUTED

## 14. Holding Review Table

  --------------------------------------------------------------------------------------------------
  Ticker         Weight Score/Rank   Confidence   Thesis   Valuation   Risk    Opportunity   Final
                                                                               Cost          State
  ---------- ---------- ------------ ------------ -------- ----------- ------- ------------- -------
  NOT               --- ---          ---          ---      ---         ---     ---           ---
  EXECUTED                                                                                   

  --------------------------------------------------------------------------------------------------

No live holding or decision is prefilled.

## 15. Human Confirmation Gate

**System → Analyze → Recommend → Explain**\
**User → Review → Approve/Reject → Execute manually**\
**After execution → Actual Transaction → Ledger → Reconciliation**

A recommendation must never directly create an executed transaction.

## 16. Behavioral Review

Explicitly test for FOMO, loss aversion, anchoring, disposition
effect/premature profit-taking, recency bias, confirmation bias, action
bias and sunk-cost thinking.

Behavioral findings trigger review; they do not arbitrarily override
evidence.

## 17. Legacy Positions

For positions acquired before VVIOS: reconstruct financial history as
evidence permits; evaluate current thesis; evaluate forward
return/opportunity cost; evaluate risk; assign current state; document
missing historical thesis rather than inventing one.

## 18. Data/Confidence Failure

If required evidence is missing or confidence fails governing
new-capital rules: do not deploy new capital merely to complete the
review; use approved PENDING/provisional handling; identify missing
evidence and refresh trigger.

## 19. Review Reproducibility

Given the same accepted portfolio snapshot, Data Snapshot ID, Scoring
Run ID and policy/model/release identity, factual inputs and
deterministic gates must reproduce. Analytical assumptions/judgments
must be recorded so differences are auditable.

## 20. Initial Portfolio Review Gates

  Gate   Requirement                                Current State
  ------ ------------------------------------------ ---------------
  PR1    Accepted portfolio snapshot available      NOT EXECUTED
  PR2    Accepted data/scoring evidence available   NOT EXECUTED
  PR3    Every holding accounted for                NOT EXECUTED
  PR4    Mandatory decision sequence applied        NOT EXECUTED
  PR5    Thesis/invalidation conditions recorded    NOT EXECUTED
  PR6    Valuation assessment complete              NOT EXECUTED
  PR7    Security/portfolio risks assessed          NOT EXECUTED
  PR8    Concentration/drawdown rules applied       NOT EXECUTED
  PR9    Opportunity cost applied where required    NOT EXECUTED
  PR10   Behavioral review complete                 NOT EXECUTED
  PR11   Final states conform to M4 semantics       NOT EXECUTED
  PR12   Human confirmation boundary preserved      NOT EXECUTED
  PR13   Decision records audit-complete            NOT EXECUTED
  PR14   No material doc/executable divergence      NOT EXECUTED
  PR15   No Critical/Major unresolved               NOT EXECUTED

Live review is accepted only when PR1--PR15 PASS.

## 21. Failure / Escalation

Broken thesis, material concentration breach, unexplained financial
discrepancy, stale/invalid data, model/implementation divergence or
unresolved policy ambiguity must not be forced into a capital action.
Use approved escalation/PENDING mechanisms and preserve evidence.

## 22. Relationship to First DCA Review

An accepted initial portfolio review feeds `FIRST_DCA_REVIEW.md`. It
does not require monthly DCA capital to be deployed. `HOLD CASH` remains
a valid portfolio action when no opportunity clears all gates and
lot/risk constraints.

## 23. Multi-Role Review

**CIO:** Risk of excessive trading to "clean up" legacy holdings. Fixed
by forward-looking M4 logic and no automatic liquidation. Critical 0;
Major 0.

**Portfolio Manager:** Ranking could dominate portfolio construction.
Fixed by mandatory concentration, risk, ownership and opportunity-cost
layers. Critical 0; Major 0.

**Equity Research Analyst:** Missing original thesis could invite
retrospective storytelling. Fixed by explicit missing-evidence state and
evidence-based current thesis. Critical 0; Major 0.

**Risk Manager:** Strong score/company could bypass concentration or
drawdown controls. Fixed by portfolio risk gates before action. Critical
0; Major 0.

**Behavioral Finance Reviewer:** Cost basis and +20% gains can anchor
decisions. Fixed by explicit behavioral controls and separation of
price/cost/intrinsic value/thesis. Critical 0; Major 0.

**QA / Model Governance:** Template approval could be mistaken for live
execution. Fixed by NOT EXECUTED fields and PR1--PR15 evidence gates.
Critical 0; Major 0.

## 24. Re-Review Result

**Critical specification issues:** 0 unresolved\
**Major specification issues:** 0 unresolved\
**Live portfolio review:** NOT EXECUTED\
**Live decision states:** NOT GENERATED\
**Trading authorization:** NOT GRANTED

## 25. Current Decision

**Document quality:** PASS FOR APPROVAL REVIEW\
**Initial portfolio review contract:** READY\
**Live review:** BLOCKED pending upstream execution evidence\
**Automatic transaction creation:** PROHIBITED

## 26. Approval Effect

When explicitly approved:

1.  promote `INITIAL_PORTFOLIO_REVIEW.md` to **Approved Baseline v1.0**;
2.  approval freezes the review contract, not live recommendations;
3.  PR1--PR15 remain evidence-dependent;
4.  no live decision may be fabricated;
5.  proceed only to the next M8 deliverable;
6.  first live portfolio decisions become valid only after
    evidence-backed execution under frozen M1--M8 controls.

**END OF DOCUMENT**
